Compile Data Set for Download or QSAR
Report error Found 253 Enz. Inhib. hit(s) with all data for entry = 10284
TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525065BDBM525065(US11168102, Example 9.)
Affinity DataKd:  0.366nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525146BDBM525146(US11168102, Example 32-31.)
Affinity DataIC50: 3.53nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525147BDBM525147(US11168102, Example 32-32.)
Affinity DataIC50: 4.77nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525070BDBM525070(US11168102, Example 18.)
Affinity DataIC50: 5.79nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524861BDBM524861(US11168102, Example 1.)
Affinity DataKd:  6.20nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524925BDBM524925(US11168102, Example 1-15.)
Affinity DataKd:  6.29nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525148BDBM525148(US11168102, Example 32-51.)
Affinity DataIC50: 6.77nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525128BDBM525128(US11168102, Example 32-19.)
Affinity DataKd:  6.92nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525044BDBM525044(US11168102, Example 2.)
Affinity DataKd:  7.36nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525132BDBM525132(US11168102, Example 57.)
Affinity DataIC50: 7.65nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525055BDBM525055(US11168102, Example 8-4.)
Affinity DataIC50: 7.66nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524864BDBM524864(US11168102, Example 1-3.)
Affinity DataKd:  7.86nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525067BDBM525067(US11168102, Example 12.)
Affinity DataKd:  7.94nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525049BDBM525049(US11168102, Example 4.)
Affinity DataKd:  7.97nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525128BDBM525128(US11168102, Example 32-19.)
Affinity DataIC50: 8.82nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524861BDBM524861(US11168102, Example 1.)
Affinity DataIC50: 9nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525132BDBM525132(US11168102, Example 57.)
Affinity DataKd:  9.19nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525049BDBM525049(US11168102, Example 4.)
Affinity DataIC50: 10.8nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525065BDBM525065(US11168102, Example 9.)
Affinity DataIC50: 11.9nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525071BDBM525071(US11168102, Example 19.)
Affinity DataIC50: 12.3nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525056BDBM525056(US11168102, Example 8-5.)
Affinity DataIC50: 12.8nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524950BDBM524950(US11168102, Example 1-18.)
Affinity DataIC50: 12.8nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525044BDBM525044(US11168102, Example 2.)
Affinity DataIC50: 12.9nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524948BDBM524948(US11168102, Example 1-17.)
Affinity DataIC50: 13nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524863BDBM524863(US11168102, Example 1-2.)
Affinity DataKd:  13.4nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525142BDBM525142(US11168102, Example 24.)
Affinity DataIC50: 13.5nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525067BDBM525067(US11168102, Example 12.)
Affinity DataIC50: 13.6nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524910BDBM524910(US11168102, Example 1-13.)
Affinity DataKd:  13.8nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525120BDBM525120(US11168102, Example 28-6.)
Affinity DataIC50: 14nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525124BDBM525124(US11168102, Example 29-5.)
Affinity DataIC50: 14.8nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525126BDBM525126(US11168102, Example 31-1.)
Affinity DataIC50: 15nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525054BDBM525054(US11168102, Example 8-3.)
Affinity DataIC50: 15nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525035BDBM525035(US11168102, Example 1-22.)
Affinity DataKd:  15.1nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525088BDBM525088(US11168102, Example 25.)
Affinity DataIC50: 15.9nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525123BDBM525123(US11168102, Example 29-4.)
Affinity DataIC50: 15.9nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525070BDBM525070(US11168102, Example 18.)
Affinity DataKd:  16nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524880BDBM524880(US11168102, Example 1-5.)
Affinity DataKd:  16.3nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525126BDBM525126(US11168102, Example 31-1.)
Affinity DataKd:  16.4nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525050BDBM525050(US11168102, Example 6.)
Affinity DataKd:  17.3nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525072BDBM525072(US11168102, Example 21.)
Affinity DataIC50: 18nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524881BDBM524881(US11168102, Example 1-6.)
Affinity DataKd:  18.2nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524915BDBM524915(US11168102, Example 1-14.)
Affinity DataKd:  19nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525145BDBM525145(US11168102, Example 32-24.)
Affinity DataIC50: 19.1nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524910BDBM524910(US11168102, Example 1-13.)
Affinity DataIC50: 19.3nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525088BDBM525088(US11168102, Example 25.)
Affinity DataKd:  19.4nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525086BDBM525086(US11168102, Example 23.)
Affinity DataKd:  19.8nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524884BDBM524884(US11168102, Example 1-8.)
Affinity DataKd:  20nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 525042BDBM525042(US11168102, Example 1-30.)
Affinity DataKd:  20.1nMAssay Description:The purpose of this assay was to characterize the inhibitory activity of compounds on SOS1 nucleotide exchange of KRAS. Data was reported as IC50 val...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524884BDBM524884(US11168102, Example 1-8.)
Affinity DataIC50: 20.1nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSon of sevenless homolog 1 [564-1049](Human)
Revolution Medicines

US Patent
LigandChemical structure of BindingDB Monomer ID 524933BDBM524933(US11168102, Example 1-16.)
Affinity DataIC50: 20.4nMAssay Description:Using a GE Biacore 8K SPR instrument, avi-tagged SOS1 catalytic domain protein was immobilized to a level of approximately 6000 response units (RU) o...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

Displayed 1 to 50 (of 253 total ) | Next | Last >>
Jump to: